Urological Diagnostics and Clinical Management Protocols

Classified in Medicine & Health

Written on in English with a size of 3.22 KB

Urological Symptom Assessment

  • Macrohematuria: Cancer
  • Fever: Infection (Prostatitis/Obstructive Pyelonephritis)
  • CANT: Acute Urinary Retention (ARU)
  • NO: Trauma
  • Decreased Flow: BPH/Prostate Cancer
Urine Flow IssuesFlank PainCancer Screening
  • Inspect
  • IPSS
  • PSA
  • US
  • Uroflowmetry
  • Residual Volume
  • DRE
  • Biopsy
  • UA
  • US
  • Urogram
  • Contusion: UA, CBC, US, Helical CT Abdomen
  • CBC
  • UA
  • PSA
  • Coagulation Test (PT/INR)
  • DRE
  • US
  • Cystoscopy

Stone Diagnostics

  • UA
  • 24-Hour Urine (Cr, Ca)
  • Biochemistry (BUN, Cr)
  • CT Scan

Differential Diagnoses

  • Acute Prostatitis / Acute Pyelonephritis (Sinistra)
  • Carcinoma Vesicae Urinariae / Hyperplasia Glandulae Prostatae

Medication: Combodart

  • Alpha-1 Adrenergic Antagonist: Tamsulosin 0.4mg/day
  • 5-Alpha Reductase Inhibitor: Finasteride 5mg/day

Laboratory Reference Ranges

Blood ParametersUrinalysis (UA)
  • RBC: 4.6–6.2 x 10¹²/L
  • Leukocytes: 3.5–12.0 x 10⁹/L
  • Cr: 50–110 μmol/L
  • Hb: 120–160 g/L
  • Albumin: 35–50 g/L
  • Urea: 2.8–8.2 mmol/L
  • Ferritin: 20–200 ng/mL
  • ESR: 0–15 mm/hr
  • CRP: <1 mg/L
  • Platelets: 150–400 x 10⁹/L
  • pH: 4.5–8.0
  • Blood: ≤3 RBCs
  • Protein: ≤150 mg/day
  • RBCs: ≤2 RBCs/hpf
  • WBCs: ≤2–5 WBCs/hpf
  • Specific Gravity: 1.003–1.030

Chronic Conditions and Medications

  • Infection: Cefuroxime 500mg (1-2 days/OP)
  • Diuretics: Furosemide 60mg (1/day)
  • Antihypertensives: Ramipril 20mg, Nifedipine 20mg, Valsartan 160mg
  • Conditions: ANCA Vasculitis, Pauci-immune RPGN, Diabetic Nephropathy, Chronic Renal Failure, Anemia, Secondary Hypertension

Multiple Myeloma Management

  • Supportive Care: Rehydration, treat hypercalcemia (bisphosphonates), treat hyperuricemia (allopurinol), stop NSAIDs
  • Reduce Light Chains: High-dose dexamethasone (40mg daily), plasma exchange
  • Chemotherapy: Melphalan, Thalidomide, Myeloablative treatment

Related entries: